CLINICAL_TRIALS
trial_result
· 2014-02-17
Clinical Trial Update: A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients [Phase 1]
Summary
A Phase 1 study of PF-00868554 in hepatitis C virus–positive patients has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2014-02-17